SCHEMBL30304159

SCHEMBL30304159

[2H]c1c([2H])c([2H])c2c(-c3cccc4ccccc34)c3c([2H])c([2H])c([2H])c([2H])c3cc2c1[2H]

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 1/20 0.38
▸ CES1 P23141 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALPL P05186 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ TYMP P19971 1/20 0.37
▸ GSK3B P49841 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CDK5 Q00535 1/20 0.36
▸ CDK5R1 Q15078 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ HPGD P15428 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ CASP1 P29466 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ GPR84 Q9NQS5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23674867 0.89 DHFR (0.38) DHFRKDM4EALPLGAATYMP
SCHEMBL29351753 0.89 DHFR (0.38) DHFRKDM4EALPLGAATYMP
SCHEMBL30548346 0.85 DHFR (0.36) DHFRCES1KDM4EALPLGAA
SCHEMBL29834223 0.82 DHFR (0.38) DHFRKDM4EALPLGAATYMP
SCHEMBL30302915 0.80 GPR84 (0.40) CES1KDM4EMEN1KMT2AALDH1A1
SCHEMBL30257836 0.80 TYMP (0.35) DHFRKDM4ETYMPALDH1A1HSD17B10
SCHEMBL30302844 0.80 CES1 (0.38) CES1KDM4EMEN1KMT2AALDH1A1
SCHEMBL338172 0.78 CES1 (0.55) DHFRCES1KDM4EALPLGAA
SCHEMBL30608462 0.78 ALOX5 (0.35) CES1KDM4EGAAMEN1KMT2A
SCHEMBL30608441 0.78 ALOX5 (0.48) KDM4EGAAMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116041296-B Compounds, mixtures and organic electronic devices 深圳市华星光电半导体显示技术有限公司 2025-02-28 — — CN disclosed
US-20240268226-A1 COMPOUND, COMPOSITION, AND ORGANIC ELECTRONIC DEVICE SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2024-08-08 — — US disclosed
CN-116547255-A Methods, reaction compositions, deuterated anthracene compounds, and compositions for preparing deuterated anthracene compounds 株式会社LG化学 2023-08-04 — — CN disclosed
CN-116041296-A Compounds, mixtures and organic electronic devices 深圳市华星光电半导体显示技术有限公司 2023-05-02 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240268226-A1 COMPOUND, COMPOSITION, AND ORGANIC ELECTRONIC DEVICE ESR1, AR, CHRM1 DHFR 4699/4885CES1 1995/4885KDM4E 2682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback